133 related articles for article (PubMed ID: 12720127)
1. Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias.
Mitsiades CS; Mitsiades N; Treon SP; Anderson KC
Semin Oncol; 2003 Apr; 30(2):156-60. PubMed ID: 12720127
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
[TBL] [Abstract][Full Text] [Related]
3. Genomics and proteomics in multiple myeloma and Waldenström macroglobulinemia.
Henry T; Fonseca R
Curr Opin Hematol; 2007 Jul; 14(4):369-74. PubMed ID: 17534163
[TBL] [Abstract][Full Text] [Related]
4. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
5. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin M myeloma: evaluation of molecular features and cytokine expression.
Konduri K; Sahota SS; Babbage G; Tong AW; Kumar P; Newman JT; Stone MJ
Clin Lymphoma; 2005 Mar; 5(4):285-9. PubMed ID: 15794867
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Chng WJ; Schop RF; Price-Troska T; Ghobrial I; Kay N; Jelinek DF; Gertz MA; Dispenzieri A; Lacy M; Kyle RA; Greipp PR; Tschumper RC; Fonseca R; Bergsagel PL
Blood; 2006 Oct; 108(8):2755-63. PubMed ID: 16804116
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
Roccaro AM; Leleu X; Sacco A; Moreau AS; Hatjiharissi E; Jia X; Xu L; Ciccarelli B; Patterson CJ; Ngo HT; Russo D; Vacca A; Dammacco F; Anderson KC; Ghobrial IM; Treon SP
Clin Cancer Res; 2008 Mar; 14(6):1849-58. PubMed ID: 18347188
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
[TBL] [Abstract][Full Text] [Related]
11. The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.
Hatzimichael E; Dasoula A; Shah R; Syed N; Papoudou-Bai A; Coley HM; Dranitsaris G; Bourantas KL; Stebbing J; Crook T
Eur J Haematol; 2010 Jan; 84(1):47-51. PubMed ID: 19737309
[TBL] [Abstract][Full Text] [Related]
12. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiles of proteasome inhibition in plasma cell dyscrasias.
Mitsiades CS
J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S23-7. PubMed ID: 19795532
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
15. [Myeloma, waldenström's disease and gamma globulin Gm and Inv groups].
Ropartz C; Rivat L; Rousseau PY; Fine JM
Rev Fr Etud Clin Biol; 1965 May; 10(5):507-13. PubMed ID: 4157918
[No Abstract] [Full Text] [Related]
16. High-throughput genomic analysis in Waldenström's macroglobulinemia.
Poulain S; Braggio E; Roumier C; Aijjou R; Broucqsault N; Galiègue-Zouitina S; Manier S; Soenen V; Nibourel O; Duthilleul P; Fonseca R; Leleu X
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):106-8. PubMed ID: 21454205
[TBL] [Abstract][Full Text] [Related]
17. Skeletal clues apparently distinguishing Waldenstrom's macroglobulinemia from multiple myeloma and leukemia.
Rothschild BM; Ruhli F; Rothschild C
Am J Hum Biol; 2002; 14(4):532-7. PubMed ID: 12112574
[TBL] [Abstract][Full Text] [Related]
18. Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma.
Wagner SD; Martinelli V; Luzzatto L
Blood; 1994 Jun; 83(12):3647-53. PubMed ID: 8204889
[TBL] [Abstract][Full Text] [Related]
19. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy.
Treon SP; Shima Y; Preffer FI; Doss DS; Ellman L; Schlossman RL; Grossbard ML; Belch AR; Pilarski LM; Anderson KC
Semin Oncol; 1999 Oct; 26(5 Suppl 14):97-106. PubMed ID: 10561024
[TBL] [Abstract][Full Text] [Related]
20. The BLIMP1-EZH2 nexus in a non-Hodgkin lymphoma.
Anderson KJ; Ósvaldsdóttir ÁB; Atzinger B; Traustadóttir GÁ; Jensen KN; Lárusdóttir AE; Bergthórsson JT; Hardardóttir I; Magnúsdóttir E
Oncogene; 2020 Jul; 39(28):5138-5151. PubMed ID: 32533097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
